Page last updated: 2024-08-23

dobutamine and rolipram

dobutamine has been researched along with rolipram in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hisaoka, T; Kobayashi, S; Kohno, M; Matsuzaki, M; Mochizuki, M; Ohkusa, T; Ono, K; Tanigawa, T; Yamada, J; Yano, M1
De Santis, V; Mazzesi, G; Miraldi, F; Ozdem, SS; Papalia, U; Puddu, PE; Tritapepe, L; Usta, C; Vitale, D1
Huang, Y; Mishler, K; O'Donnell, JM; Roerig, SC; Zhang, HT1

Other Studies

3 other study(ies) available for dobutamine and rolipram

ArticleYear
Effect of milrinone on left ventricular relaxation and Ca(2+) uptake function of cardiac sarcoplasmic reticulum.
    American journal of physiology. Heart and circulatory physiology, 2000, Volume: 279, Issue:4

    Topics: Adrenergic beta-Agonists; Animals; Calcium; Calcium-Transporting ATPases; Cardiotonic Agents; Cyclic AMP; Cyclic GMP; Dobutamine; Dogs; Hemodynamics; Milrinone; Myocardium; Phosphodiesterase Inhibitors; Rolipram; Sarcoplasmic Reticulum; Ventricular Function, Left

2000
Comparision of the inotropic effects of levosimendan, rolipram, and dobutamine on human atrial trabeculae.
    Journal of cardiovascular pharmacology, 2004, Volume: 44, Issue:5

    Topics: Adult; Aged; Cardiotonic Agents; Coronary Artery Disease; Dobutamine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electric Stimulation; Female; Heart Atria; Heart Valve Diseases; Humans; Hydrazones; Male; Middle Aged; Myocardial Contraction; Pyridazines; Rheumatic Heart Disease; Rolipram; Simendan; Troponin C

2004
Interaction between the antidepressant-like behavioral effects of beta adrenergic agonists and the cyclic AMP PDE inhibitor rolipram in rats.
    Psychopharmacology, 2005, Volume: 182, Issue:1

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Agonists; Animals; Antidepressive Agents; Appetitive Behavior; Cells, Cultured; Cerebral Cortex; Clenbuterol; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Discrimination Learning; Dobutamine; Dose-Response Relationship, Drug; Drug Interactions; In Vitro Techniques; Injections, Intraperitoneal; Male; Neurons; Phosphodiesterase Inhibitors; Rats; Rats, Sprague-Dawley; Reinforcement Schedule; Rolipram; Signal Transduction

2005